Following this point of view, although the results of molecular docking supported the existence of affinity potential of TIZ with CDK1, CDK2, and CDK4, we only performed siRNA targeting CDK1 to verify the inhibitory effect of TIZ on the proliferation of gliomas. Here, CDK1 is linked to central nervous system cancer.